{"disease":{"id":"treatment-naive-aml","name":"treatment naive aml"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02203773","title":"Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":212,"lead_sponsor_name":"AbbVie","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}